ChristopherTSiegelMDPhD

Hepatobiliary Surgery, Transplantation

Assoc. Professor of Surgery, Cleveland Clinic Lerner College of Medicine, Contract Staff Cleveland Clinic Foundation

Dr. Siegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6770 Mayfield Rd Suite 421
Cleveland, OH 44124
Phone+1 440-449-1101

Fax+1 216-444-9423

PubMed

Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.
Kenneth K Tanabe, David Zahrieh, Carrie A Strand, Yujin Hoshida, Thomas J Flotte
Gastro Hep Advances. 2024-01-01
2 citations
Diagnosis and staging of hepatobiliary malignancies: Potential incremental value of (18)F-FDG-PET/MRI compared to MRI of the liver.
Verena Carola Obmann, Nils Grosse-Hokamp, Ian Alberts, Nicholas Lim Fulton, Negin Rassouli
Nuklearmedizin. Nuclear Medicine. 2021-06-08
9 citations
Functional liver tissue engineering by an adult mouse liver-derived neuro-glia antigen 2-expressing stem/progenitor population.
Hongyu Zhang, Christopher T. Siegel, Jing Li, Lai Jiejuan, Ling Shuai
Journal of Tissue Engineering and Regenerative Medicine. 2018-01-01